Form 4: Amgen EVP Jonathan P. Graham Reports Stock Disposal for Tax Obligations

Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., reports disposing of 632 shares of common stock to cover tax obligations related to vested Restricted Stock Units.

Summary

• On May 5, 2024, Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., disposed of 632 shares of Amgen common stock.
• The transaction was executed at a price of $311.29 per share.
• The disposal was related to covering tax obligations.
• Following the transaction, Graham directly owns 32,323 shares of Amgen common stock, which includes Restricted Stock Units (RSUs) and Dividend Equivalents (DEs).

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations, so it doesn't necessarily indicate positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like executives and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units (RSUs) as a way to align management's interests with those of shareholders.
• The disposal of shares to cover tax obligations upon vesting of RSUs is a common practice among executives.
• Companies like Johnson & Johnson, Pfizer, and Merck also have executives who regularly file Form 4s for similar transactions.

Key Dates